These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 17117102)

  • 21. Histopathology of brow fat in thyroid-associated orbitopathy.
    Hwang CJ; Khadavi NM; Papageorgiou K; Said J; Chong K; Lee D; Smith TJ; Goldberg RA; Douglas RS
    Ophthalmic Plast Reconstr Surg; 2012; 28(1):27-9. PubMed ID: 22082595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid Stimulating Antibodies Are Highly Prevalent in Hashimoto's Thyroiditis and Associated Orbitopathy.
    Kahaly GJ; Diana T; Glang J; Kanitz M; Pitz S; König J
    J Clin Endocrinol Metab; 2016 May; 101(5):1998-2004. PubMed ID: 26964732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease.
    Stein JD; Childers D; Gupta S; Talwar N; Nan B; Lee BJ; Smith TJ; Douglas R
    JAMA Ophthalmol; 2015 Mar; 133(3):290-6. PubMed ID: 25502604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
    Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
    J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Thyroid-associated ophthalmopathy: a clinical study of 381 cases].
    Sun H; Jiao Q; Tan L; Wang S; Ning G; Zhao YJ
    Zhonghua Nei Ke Za Zhi; 2006 May; 45(5):400-2. PubMed ID: 16780745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Pro 12 Ala PPAR gamma gene polymorphism: possible modifier of the activity and severity of thyroid-associated orbitopathy (TAO).
    Alevizaki M; Mantzou E; Cimponeriu A; Saltiki K; Philippou G; Wiersinga W
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):464-8. PubMed ID: 18624999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between thyroid autoimmune dysfunction and non-thyroid autoimmune diseases.
    Cruz AA; Akaishi PM; Vargas MA; de Paula SA
    Ophthalmic Plast Reconstr Surg; 2007; 23(2):104-8. PubMed ID: 17413622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of graves myopathy: Thyroid-associated orbitopathy: when should we operate?
    Seiff SR; Wagner LH
    J AAPOS; 2018 Aug; 22(4):251-252. PubMed ID: 29330045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Customized Orbital Decompression Surgery Combined with Eyelid Surgery or Strabismus Surgery in Mild to Moderate Thyroid-associated Ophthalmopathy.
    Choi SW; Lee JY; Lew H
    Korean J Ophthalmol; 2016 Feb; 30(1):1-9. PubMed ID: 26865797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are ethnicity, social grade, and social deprivation associated with severity of thyroid-associated ophthalmopathy?
    Edmunds MR; Huntbach JA; Durrani OM
    Ophthalmic Plast Reconstr Surg; 2014; 30(3):241-5. PubMed ID: 24608325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orbital lymphoma associated with Graves' disease: A case report.
    Hajduković Z; Kuzmić-Janković S; Kljaković-Avramović T; Sekulović L; Tukić L
    Vojnosanit Pregl; 2014 May; 71(5):510-4. PubMed ID: 26137719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Observation of Corneal Langerhans Cells by In Vivo Confocal Microscopy in Thyroid-Associated Ophthalmopathy.
    Wu LQ; Cheng JW; Cai JP; Le QH; Ma XY; Gao LD; Wei RL
    Curr Eye Res; 2016 Jul; 41(7):927-32. PubMed ID: 26735162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical investigation of tarsorrhaphy suture for treatment thyroid-associated ophthalmopathy].
    Luo QL; Tang L; He WM
    Zhonghua Yan Ke Za Zhi; 2005 Sep; 41(9):777-80. PubMed ID: 16191341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical analysis of 106 cases with elevated intraocular pressure in thyroid-associated ophthalmopathy.
    He J; Wu Z; Yan J; Yang H; Mao Y; Ai S; Chen Z
    Yan Ke Xue Bao; 2004 Mar; 20(1):10-4. PubMed ID: 15124526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Orbital-bony decompression in patients with dysthyroid orbitopathy--first Croatian experiences].
    Juri J; Stiglmayer N; Kuzman T
    Acta Med Croatica; 2006; 60(2):83-6. PubMed ID: 16848193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reevaluation of the prevalences of serum autoantibodies reactive with "64-kd eye muscle proteins" in patients with thyroid-associated ophthalmopathy.
    Kubota S; Gunji K; Stolarski C; Kennerdell JS; Wall J
    Thyroid; 1998 Feb; 8(2):175-9. PubMed ID: 9510127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The pathological changes of the orbital tissue in thyroid associated ophthalmopathy].
    Hei Y; Kang L; Li YY; Xiao LH
    Zhonghua Yan Ke Za Zhi; 2008 May; 44(5):423-6. PubMed ID: 18953897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy.
    Tong BD; Xiao MY; Zeng JX; Xiong W
    Mol Vis; 2015; 21():324-34. PubMed ID: 25873777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance imaging and ultrasound measurements of extraocular muscles in thyroid-associated ophthalmopathy at different stages of the disease.
    Lennerstrand G; Tian S; Isberg B; Landau Högbeck I; Bolzani R; Tallstedt L; Schworm H
    Acta Ophthalmol Scand; 2007 Mar; 85(2):192-201. PubMed ID: 17305734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyaluronic acid induces COX-2 expression via CD44 in orbital fibroblasts from patients with thyroid-associated ophthalmopathy.
    Lim HS; Back KO; Kim HJ; Choi YH; Park YM; Kook KH
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7441-50. PubMed ID: 25342622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.